Closing Thought

Oct 01, 2012
Applied Clinical Trials
By Applied Clinical Trials Editors
Modeling and simulation has been heralded for some time as a possible answer to the industry's woes.
Sep 01, 2012
Applied Clinical Trials
By Applied Clinical Trials Editors
Demonstrating biosimilarity is highly dependent on the unique characteristics of the product.
Aug 01, 2012
Applied Clinical Trials
By Applied Clinical Trials Editors
Quality is not just a way to gratify sponsors or authorities, but should be part an established and dynamic QMS.
Jul 01, 2012
Applied Clinical Trials
By Applied Clinical Trials Editors
Prior to initiating a trial with ED sites, three factors must be considered in order to achieve success.
Jun 01, 2012
Applied Clinical Trials
By Applied Clinical Trials Editors
A well designed CTCP can keep everyone motivated and focused on achieving trial objectives.
May 01, 2012
Applied Clinical Trials
The adoption of new, consistent definitions are needed to help demystify late phase trials.
Apr 01, 2012
Applied Clinical Trials
By Applied Clinical Trials Editors
Researchers who work on HIV vaccines face a major challenge: convincing members of at-risk communities to volunteer for these trials.
Mar 01, 2012
Applied Clinical Trials
By Applied Clinical Trials Editors
Choosing eClinical solutions can appear to be a tricky situation.
Feb 01, 2012
Applied Clinical Trials
All measurements and outcomes need to reflect what is happening with the patient.
Jan 01, 2012
Applied Clinical Trials
While risk and uncertainty remain high, the pace of innovation will remain glacial.
native1_300x100
lorem ipsum